Results 201 to 210 of about 19,908 (254)

Correction: Use of ketamine in super refractory status epilepticus: a systematic review. [PDF]

open access: yesNeurol Res Pract
Adhikari A   +10 more
europepmc   +1 more source

Prognostic Value of Signal Abnormalities on Brain MRI in Post-Anoxic Super-Refractory Status Epilepticus: A Single-Center Retrospective Study. [PDF]

open access: yesEur J Neurol
Diamanti S   +12 more
europepmc   +1 more source

Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus

Continuum, 2022
Status epilepticus is a serious condition caused by disorders and diseases that affect the central nervous system. In status epilepticus, hypersynchronous epileptic activity lasts longer than the usual duration of isolated self-limited seizures (time t1), which causes neuronal damage or alteration of neuronal networks at a certain time point (time t2),
Eugen, Trinka, Markus, Leitinger
openaire   +2 more sources

Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus

Continuum, 2018
Status epilepticus, refractory status epilepticus, and super-refractory status epilepticus can be life-threatening conditions. This article presents an overview of the three conditions and discusses their management and outcomes.Status epilepticus was previously defined as lasting for 30 minutes or longer but now is more often defined as lasting 5 ...
Sarah E, Nelson, Panayiotis N, Varelas
openaire   +2 more sources

Super-Refractory Status Epilepticus

Current Neurology and Neuroscience Reports, 2015
Although the vast majority of patients with status epilepticus (SE) respond fairly well to the first- or second-line anti-epileptics, a minority require anesthetic agents to put the seizures under control. An even smaller number of patients do not even respond to those and constitute the subgroup of super-refractory SE.
Mauricio Ruiz, Cuero   +1 more
openaire   +3 more sources

Refractory status epilepticus

Current Opinion in Critical Care, 2012
Refractory status epilepticus (RSE) has a high morbidity and mortality. There are currently no definitive data to guide both the optimal choice of therapy and treatment goals. This review focuses on RSE diagnosis and outcome and discusses both commonly used and anecdotal therapies for RSE.The challenges in performing randomized controlled trials (RCTs)
Andres, Fernandez, Jan, Claassen
openaire   +2 more sources

Home - About - Disclaimer - Privacy